Immix Biopharma, Inc.
IMMX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001873835
No open-market purchases or sales by Immix Biopharma, Inc. insiders were filed in the last 90 days; 109 institutions reported holding it in 13F filings for Q2 2026, worth $579.6M in total; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in Immix Biopharma, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 28
- +12 vs. Q3 2023
- Shares held
- 781.8K
- +376.8K (+93.0%) vs. Q3 2023
- Total value
- $5.32M
- +$3.93M (+283.7%) vs. Q3 2023
- New holders
- 13
- 7 more added
- Sold out
- 1
- 3 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IMMX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 109 | $579.6M |
| Q1 2026 | 77 | $246.6M |
| Q4 2025 | 67 | $127.5M |
| Q3 2025 | 31 | $5.78M |
| Q2 2025 | 23 | $4.68M |
| Q1 2025 | 22 | $4.90M |
| Q4 2024 | 23 | $6.32M |
| Q3 2024 | 25 | $6.10M |
| Q2 2024 | 31 | $8.77M |
| Q1 2024 | 35 | $15.7M |
| Q4 2023 | 28 | $5.32M |
| Q3 2023 | 16 | $1.39M |
| Q2 2023 | 18 | $1.75M |
| Q1 2023 | 12 | $729.8K |
| Q4 2022 | 18 | $1.01M |
| Q3 2022 | 12 | $406.0K |
| Q2 2022 | 7 | $475.0K |
| Q1 2022 | 8 | $352.0K |
| Q4 2021 | 11 | $5.47M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Immix Biopharma, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 160,398 | $1.11M | 0.00% | +54,188+51.0% | Added |
| EAM Investors, LLC | 102,661 | $710.4K | 0.13% | +102,661 | New |
| Private Advisor Group, LLC | 99,775 | $690.4K | 0.01% | +99,775 | New |
| Geode Capital Management, LLC | 83,427 | $577.4K | 0.00% | +10,405+14.2% | Added |
| State Street Corp | 42,960 | $297.3K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 32,400 | $224.0K | 0.00% | +32,400 | New |
| Commonwealth Equity Services, LLC | 28,300 | $196.0K | 0.00% | −555−1.9% | Reduced |
| Northern Trust Corp | 24,378 | $168.7K | 0.00% | +24,378 | New |
| Imprint Wealth LLC | 34,483 | $143.2K | 0.12% | +11,400+49.4% | Added |
| Moss Adams Wealth Advisors LLC | 20,000 | $138.4K | 0.03% | 00.0% | Unchanged |
| Tocqueville Asset Management L.P. | 20,000 | $138.4K | 0.00% | +8,000+66.7% | Added |
| Jump Financial, LLC | 18,500 | $128.0K | 0.00% | +18,500 | New |
| BlackRock Inc. | 17,712 | $122.6K | 0.00% | −279−1.6% | Reduced |
| Morgan Stanley | 16,168 | $111.9K | 0.00% | +15,768+3,942.0% | Added |
| Jane Street Group, LLC | 14,922 | $103.3K | 0.00% | +14,922 | New |
| Susquehanna International Group, LLP | 14,351 | $99.3K | 0.00% | +14,351 | New |
| Dimensional Fund Advisors LP | 11,915 | $82.5K | 0.00% | 00.0% | Unchanged |
| InterOcean Capital Group, LLC | 11,900 | $82.3K | 0.00% | −4,000−25.2% | Reduced |
| Bank of Montreal | 10,000 | $72.0K | 0.00% | +10,000 | New |
| Old National Bancorp | 10,000 | $69.2K | 0.00% | +10,000 | New |
| UBS Group AG | 2,628 | $18.2K | 0.00% | +2,628 | New |
| Bank of America Corp | 1,594 | $11.0K | 0.00% | +1,594 | New |
| Tortoise Investment Management, LLC | 1,300 | $9.00K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 678 | $4.69K | 0.00% | +671+9,585.7% | Added |
| Tower Research Capital LLC (TRC) | 577 | $3.99K | 0.00% | +577 | New |
| Wells Fargo & Company | 391 | $2.71K | 0.00% | +334+586.0% | Added |
| Advisor Group Holdings, Inc. | 350 | $2.42K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 68 | $0 | 0.00% | +68 | New |
| Koshinski Asset Management, Inc. | 0 | $0 | 0.00% | −51,001−100.0% | Sold out |